Main Street Group’s AbbVie ABBV Stock Holding History

Main Street Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$700K	Sell	2,780 -173	-6%	-$37.2K	0.16%	49
2026 Q1	$642K	Sell	2,953 -25	-0.8%	-$5.55K	0.19%	50
2025 Q4	$681K	Sell	2,978 -347	-10%	-$79K	0.23%	39
2025 Q3	$770K	Buy	3,325 +31	+0.9%	+$6.31K	0.23%	43
2025 Q2	$611K	Sell	3,294 -686	-17%	-$127K	0.2%	46
2025 Q1	$834K	Buy	3,980 +12	+0.3%	+$2.33K	0.32%	39
2024 Q4	$705K	Sell	3,968 -18	-0.5%	-$3.31K	0.26%	44
2024 Q3	$787K	Sell	3,986 -182	-4%	-$34K	0.31%	36
2024 Q2	$710K	Sell	4,168 -62	-1%	-$10.3K	0.3%	41
2024 Q1	$765K	Buy	4,230 +443	+12%	+$76.3K	0.33%	40
2023 Q4	$587K	Buy	+3,787	New	+$552K	0.2%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Main Street Group's ABBV Position: Q2 2026 in Review

Main Street Group reduced its AbbVie (ABBV) stake by 5.9% in Q2 2026, selling an estimated $37.2K and leaving 2,780 shares worth $700K. The position accounts for 0.16% of the portfolio, ranked #49.

Main Street Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $834K in Q1 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Main Street Group held 2,780 shares of AbbVie worth $700K as of Q2 2026.
Main Street Group sold 173 AbbVie shares in Q2 2026, an estimated $37.2K.
AbbVie made up 0.16% of Main Street Group's portfolio in Q2 2026, its #49 holding.
Main Street Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Main Street Group's AbbVie position peaked at $834K in Q1 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.